• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Proqr Therapeutics (NQ: PRQR )

3.686 +0.186 (+5.31%)
Streaming Delayed Price Updated: 3:40 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Proqr Therapeutics

< Previous 1 2 3 4 Next >
ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration
December 22, 2022
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 22, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Thursday! 
Via InvestorPlace
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform
December 22, 2022
From ProQR Therapeutics N.V.
Via GlobeNewswire
Lilly and ProQR to Expand RNA Editing Collaboration
December 22, 2022
New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology 
From ProQR Therapeutics N.V.
Via GlobeNewswire
Raymond James Bullish On This Penny Stock's Reprioritized Pipeline
August 12, 2022
Via Benzinga
This Penny Stock Biotech Offloads Eye Portfolio To Focus On RNA-Editing
August 11, 2022
Via Benzinga
ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022
November 14, 2022
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Announces Third Quarter 2022 Operating and Financial Results
November 09, 2022
From ProQR Therapeutics N.V.
Via GlobeNewswire
ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference
November 03, 2022
From ProQR Therapeutics N.V.
Via GlobeNewswire
Expert Ratings for ProQR Therapeutics
May 06, 2022
Within the last quarter, ProQR Therapeutics (NASDAQ:PRQR) has observed the following analyst ratings: 
Via Benzinga
Where ProQR Therapeutics Stands With Analysts
April 14, 2022
Analysts have provided the following ratings for ProQR Therapeutics (NASDAQ:PRQR) within the last quarter: 
Via Benzinga
ProQR Therapeutics Pulls Plug On Inherited Retinal Disease Programs, Cuts 30% Workforce
April 13, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
August 12, 2022
  
Via Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
May 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
February 14, 2022
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (... 
Via Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
June 28, 2022
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
May 02, 2022
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks... 
Via Benzinga
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid
April 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
April 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
April 29, 2022
On Friday, 213 companies hit new 52-week lows. 
Via Benzinga
Where ProQR Therapeutics Stands With Analysts
February 14, 2022
Analysts have provided the following ratings for ProQR Therapeutics (NASDAQ:PRQR) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish... 
Via Benzinga
Mid-Afternoon Market Update: US Stocks Extend Losses; Dow Tumbles 450 Points
February 11, 2022
US stocks extended losses toward the end of trading session, with the Dow Jones tumbling 450 points on Friday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 16, 2022
On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
February 14, 2022
Upgrades According to Mizuho, the prior rating for Murphy Oil Corp (NYSE:MUR) was changed from Neutral to Buy. In the fourth quarter, Murphy Oil showed an EPS of $0.40,... 
Via Benzinga
Mid-Day Market Update: Nasdaq Drops 100 Points; Bloom Energy Shares Jump
February 11, 2022
The Nasdaq turned lower during the mid-day session, with the tech-laden index falling 100 points on Friday. 
Via Benzinga
78 Biggest Movers From Friday
February 14, 2022
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
Via Benzinga
41 Stocks Moving In Friday's Mid-Day Session
February 11, 2022
Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations... 
Via Benzinga
52 Weeks High And Low Article
February 11, 2022
On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap